The Human-Specific miR-6762-5p Is an Activator of RhoA GTPase Enhancing Shigella flexneri Intercellular Spreading

Caroline Reisacher1, Estelle Saifi1, Elisabeth Ageron1

  • 1Université Paris Cité, INSERM, CNRS, Institut Necker Enfants Malades, Paris, France.

Molecular Microbiology
|February 24, 2025
PubMed

Insights

Newly discovered microRNA miR-6762-5p promotes Shigella infection by remodeling the host cytoskeleton. Inhibition of this microRNA reduces bacterial spread, offering a potential target for controlling Shigella dissemination.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Immunology

Background:

  • MicroRNAs (miRNAs) are key regulators in host-pathogen interactions.
  • They can either support host defense or be exploited by pathogens.
  • The role of specific miRNAs in Shigella infection is an active area of research.

Purpose of the Study:

  • To identify novel microRNAs involved in host-Shigella interplay.
  • To elucidate the function of the newly evolved human microRNA miR-6762-5p in Shigella infection.
  • To understand the mechanism by which miR-6762-5p influences bacterial dissemination.

Main Methods:

  • Microarray analysis of infected epithelial cells to detect differentially expressed miRNAs.
  • Conditional expression of miR-6762-5p and subsequent transcriptome analysis.
  • Assessment of cytoskeleton remodeling, RhoA activation, and bacterial intercellular spreading.
  • In silico analysis to identify potential miRNA targets.

Main Results:

  • miR-6762-5p was exclusively detected during the late phase of Shigella infection.
  • miR-6762-5p expression promoted stress fiber formation via RhoA activation and cytoskeleton remodeling.
  • In silico analysis identified RhoA regulators as potential targets of miR-6762-5p.
  • miR-6762-5p expression enhanced Shigella intercellular spreading, while its inhibition reduced dissemination.

Conclusions:

  • The newly evolved human microRNA miR-6762-5p is a significant factor in host-Shigella interactions.
  • miR-6762-5p facilitates Shigella dissemination by modulating host cytoskeleton dynamics through RhoA activation.
  • Targeting miR-6762-5p may represent a novel therapeutic strategy against Shigella infections.